Activity, regulation, copy number and function in the glyoxalase system

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• The glyoxalase pathway, involving glyoxalase I (Glo1) and glyoxalase II (Glo2), detoxifies reactive carbonyl species like methylglyoxal.
• Understanding the molecular, catalytic, and structural properties of glyoxalase enzymes is established.
• Current research emphasizes the regulation and physiological roles of Glo1 and Glo2 in health and disease.

Purpose of the Study:

• To review the regulatory mechanisms and therapeutic implications of glyoxalase pathway enzymes, particularly Glo1.
• To highlight the link between Glo1 activity and various health conditions, including metabolic disorders and cancer.
• To discuss the potential of modulating Glo1 activity for therapeutic interventions.

Main Methods:

• Review of existing literature on glyoxalase pathway enzyme properties, regulation, and disease associations.
• Analysis of regulatory elements in human GLO1 and HAGH (Glo2) genes.
• Inclusion of mathematical modeling predictions regarding Glo1 activity modulation.

Main Results:

• Human GLO1 possesses multiple regulatory elements (MRE, IRE, E2F4, AP-2α, ARE) and is a copy number variation hotspot.
• The human Glo2 gene (HAGH) contains a p53-response element.
• Mathematical modeling indicates that increased Glo1 activity reduces methylglyoxal, while inhibition increases it.

Conclusions:

• Glo1 is implicated in healthy aging, obesity, diabetes, cardiovascular disease, and cancer multidrug resistance.
• Pharmacological modulation of Glo1 activity presents therapeutic opportunities.
• Glo1 inducers are being developed for aging and diabetes complications; Glo1 inhibitors are explored for cancer and infectious diseases.